Compare Capital Financial Indonesia Tbk. (CASA) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Capital Financial Indonesia Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Capital Financial Indonesia Tbk. trades at Rp1,880 (market cap 98.06T, 6K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp236 (market cap 164.65B, 62.5K 24h volume). The key difference: Capital Financial Indonesia Tbk. is far larger — about 595.6× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (62.5K versus 6K). Which is the better fit depends on your goals.
| CASA | OBAT | |
|---|---|---|
Market Cap | 98.06T | 164.65B |
Volume | 6K | 62.5K |
Lot | 60 | 625 |
Turnover | 10.81M | 15.03M |
Average Price | 1,801.33 | 240.55 |
Value | 10.81M | 15.03M |
Indicative Equilibrium Price | 1,880 | 238 |
Indicative Equilibrium Volume | 1 | 100 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Capital Financial Indonesia Tbk.
PT Capital Financial Indonesia Tbk (the Company) was established under its original name of PT Baron Indonesia based on Notarial Deed No. 13 dated Juny 4, 2009 of Yulia, S.H., Notary in Jakarta.
Read more on CASA →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
